Insulin Resistance

"Insulin Resistance" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.

Descriptor ID	D007333
MeSH Number(s)	C18.452.394.968.500 G07.690.773.984.617
Concept/Terms	Insulin Resistance Insulin Resistance Resistance, Insulin Insulin Sensitivity Insulin Sensitivity Sensitivity, Insulin

Below are MeSH descriptors whose meaning is more general than "Insulin Resistance".

Diseases [C]
Nutritional and Metabolic Diseases [C18]
Metabolic Diseases [C18.452]
Glucose Metabolism Disorders [C18.452.394]
Hyperinsulinism [C18.452.394.968]
Insulin Resistance [C18.452.394.968.500]
Biological Sciences [G]
Physiological Phenomena [G07]
Pharmacological and Toxicological Phenomena [G07.690]
Pharmacological Phenomena [G07.690.773]
Drug Resistance [G07.690.773.984]
Insulin Resistance [G07.690.773.984.617]

Below are MeSH descriptors whose meaning is related to "Insulin Resistance".

Below are MeSH descriptors whose meaning is more specific than "Insulin Resistance".

Insulin Resistance
Metabolic Syndrome

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Insulin Resistance" by people in this website by year, and whether "Insulin Resistance" was a major or minor topic of these publications.

Bar chart showing 303 publications over 24 distinct years, with a maximum of 24 publications in 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	1	0	1
2002	1	2	3
2003	5	2	7
2004	6	7	13
2005	6	2	8
2006	7	6	13
2007	10	4	14
2008	9	3	12
2009	14	1	15
2010	8	4	12
2011	5	10	15
2012	10	7	17
2013	13	11	24
2014	9	9	18
2015	12	8	20
2016	12	8	20
2017	6	9	15
2018	10	2	12
2019	5	9	14
2020	6	7	13
2021	11	2	13
2022	6	0	6
2023	8	0	8
2024	4	6	10

Below are the most recent publications written about "Insulin Resistance" by people in Profiles.

Yuzefovych LV, Noh HL, Suk S, Schuler AM, Mulekar MS, Pastukh VM, Kim JK, Rachek LI. Mitochondria-Targeted DNA Repair Glycosylase hOGG1 Protects Against HFD-Induced Liver Oxidative Mitochondrial DNA Damage and Insulin Resistance in OGG1-Deficient Mice. Int J Mol Sci. 2024 Nov 13; 25(22).

View in: PubMed
Rizo-Roca D, Guimar?es DSPSF, Pendergrast LA, Di Leo N, Chibalin AV, Maqdasy S, Ryd?n M, N?slund E, Zierath JR, Krook A. Decreased mitochondrial creatine kinase 2 impairs skeletal muscle mitochondrial function independently of insulin in type 2 diabetes. Sci Transl Med. 2024 Oct 09; 16(768):eado3022.

View in: PubMed
Bai MR, Abirami K, Gayathri R, Vedantham S, Shobana S, Nagarajan LP, Gunasekaran G, Nagamuthu G, Malini HM, Gokulakrishnan K, Sandhya N, Ganesh Jeevan R, Anjana RM, Unnikrishnan R, Krishnaswamy K, Sudha V, Mohan V. Effect of low vs high dietary-advanced glycation end products on insulin-sensitivity and inflammatory- markers among overweight/obese Asian-Indian adults-A randomised controlled trial. Int J Food Sci Nutr. 2024 Dec; 75(8):835-845.

View in: PubMed
Wagner KA, Pekow P, Marcus B, Rosal MC, Braun B, Manson JE, Whitcomb BW, Sievert LL, Chasan-Taber L. The Impact of a Lifestyle Intervention on Cardiometabolic Risk Factors among Postpartum Hispanic Women with Overweight and Obesity in a Randomized Controlled Trial (Proyecto Mam?). Matern Child Health J. 2024 Oct; 28(10):1768-1781.

View in: PubMed
Lecoutre S, Maqdasy S, Rizo-Roca D, Renzi G, Vlassakev I, Alaeddine LM, Higos R, Jalkanen J, Zhong J, Zareifi DS, Frendo-Cumbo S, Massier L, Hodek O, Juvany M, Moritz T, de Castro Barbosa T, Omar-Hmeadi M, L?pez-Yus M, Merabtene F, Abatan JB, Marcelin G, El Hachem EJ, Rouault C, Bergo MO, Petrus P, Zierath JR, Cl?ment K, Krook A, Mejhert N, Ryd?n M. Reduced adipocyte glutaminase activity promotes energy expenditure and metabolic health. Nat Metab. 2024 Jul; 6(7):1329-1346.

View in: PubMed
Friedline RH, Noh HL, Suk S, Albusharif M, Dagdeviren S, Saengnipanthkul S, Kim B, Kim AM, Kim LH, Tauer LA, Baez Torres NM, Choi S, Kim BY, Rao SD, Kasina K, Sun C, Toles BJ, Zhou C, Li Z, Benoit VM, Patel PR, Zheng DXT, Inashima K, Beaverson A, Hu X, Tran DA, Muller W, Greiner DL, Mullen AC, Lee KW, Kim JK. IFN?-IL12 axis regulates intercellular crosstalk in metabolic dysfunction-associated steatotic liver disease. Nat Commun. 2024 Jun 29; 15(1):5506.

View in: PubMed
Jollet M, Tramontana F, Jiang LQ, Borg ML, Savikj M, Kuefner MS, Massart J, de Castro Barbosa T, Manner?s-Holm L, Checa A, Pillon NJ, Chibalin AV, Bj?rnholm M, Zierath JR. Diacylglycerol kinase delta overexpression improves glucose clearance and protects against the development of obesity. Metabolism. 2024 Sep; 158:155939.

View in: PubMed
Mo Z, Zhan M, Yang X, Xie P, Xiao J, Cao Y, Xiao H, Song M. Fermented dietary fiber from soy sauce residue exerts antidiabetic effects through regulating the PI3K/AKT signaling pathway and gut microbiota-SCFAs-GPRs axis in type 2 diabetic mellitus mice. Int J Biol Macromol. 2024 Jun; 270(Pt 2):132251.

View in: PubMed
Mahalingam S, Bellamkonda R, Kharbanda KK, Arumugam MK, Kumar V, Casey CA, Leggio L, Rasineni K. Role of ghrelin hormone in the development of alcohol-associated liver disease. Biomed Pharmacother. 2024 May; 174:116595.

View in: PubMed
Chen F, Mangano KM, Garelnabi M, Cardaleen K, Tucker KL. Associations among diabetes medication use, serum magnesium, and insulin resistance in a cohort of older Puerto Rican adults. Am J Clin Nutr. 2024 06; 119(6):1523-1532.

View in: PubMed

People

Explore

Similar Concepts

Top Journals